Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

High expression of Trop2 is associated with aggressive localized prostate cancer and is a candidate urinary biomarker

January 4, 2024

Stoyanova lab is excited to share our new work on identifying Trop2 protein as a novel prognostic tissue biomarker and non-invasive urinary biomarker for prostate cancer.
Congratulations!

Link to Publication: https://www.nature.com/articles/s41598-023-50215-z

January 4, 2024

NewsUCLA

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousHyeonji Hwang joins Dr. Stoyanova’s lab as a postdoctoral scholar from Seoul National University!

  • NextUCHL1 is a potential molecular indicator and therapeutic target for neuroendocrine carcinomas

Related Posts ...

Exciting news: Dr. Hyeonji Hwang, a postdoctoral fellow at Dr. Stoyanova’s Lab in UCLA, awarded the Prostate Cancer Research Program Early Investigator Research Award by the US Department of Defense (DOD) for the project titled “Targeting Trop2-Mediated Ferroptosis as a New Therapy for Advanced Prostate Cancer”

News, UCLA

Exciting News: Dr. Tanya Stoyanova receives 2025 Neuroendocrine Tumor Research Foundation Pilot Award

News, UCLA

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login